Search
Cognition Therapeutics Inc
CGTXAdd to Watchlist
0.687USD
+0.052+8.19%
Close 11-06 16:00（ET）
65.33MMarket Cap
LossP/E TTM
Today
+8.19%
5 Days
-1.58%
1 Month
-23.24%
6 Months
-43.22%
Year to Date
-49.11%
1 Year
-58.61%
Key Figures
0.645Open
0.698High
25.21KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.03%Turnover Ratio
0.635Prev. Close
0.632Low
16.68KTurnover
LossP/E Static
2.24P/B
0.00%Div Yield TTM
-65.65%ROA
1.82552wk High
0.05Volume Ratio
-33.97MNet Profit
95.09MShares
-0.2369EPS TTM
1.77Beta
-92.82%ROE
0.55052wk Low
14.96%Amplitude
--Gross Margin
65.33MMarket Cap
0.92Reward/Risk
6.08%Risk Rate
Analyst Rating
Cognition Therapeutics Inc Technical Analysis
Technical Indicators
Sell
Summary
Sell
Moving Average
Strong sell
Cognition Therapeutics Inc Latest Earnings Call Transcripts
Cognition Therapeutics (CGTX) Q3 2026 Earnings Call: DLB Phase III Plan Advances
Cognition Therapeutics’ Q3 2026 earnings call detailed its FDA-aligned zervimesine DLB Phase III plan, $31.5 million cash balance and 2027 milestones.
Earnings
Next reporting date
--
Reporting Period
2026Q3
Earnings / Forecast
-0.04/-0.07
Revenue / Forecast
--/0.00
Cognition Therapeutics Inc Profile
SectorBiotechnology & Medical Research
Ticker SymbolCGTX
Number of employees25
CountryUnited States of America
Ownership
| Shareholders | Proportion |
|---|---|
| Bios Equity Partners, LP. | 6.70% |
| Vanguard Capital Management, LLC | 3.35% |
| Davenport Asset Management | 3.23% |
| Chescapmanager, L.L.C. | 1.11% |
| Shareholder Types | Proportion |
|---|---|
| Investment Advisor | 11.40% |
| Venture Capital | 6.75% |
| Investment Advisor/Hedge Fund | 2.70% |
| Individual Investor | 2.23% |
Related Instruments
-0.79%
+1.43%
+1.07%
-0.14%
+0.38%
-0.22%
+0.03%
-0.41%
+0.02%
-0.20%
+0.85%
-1.57%
-1.04%
+0.28%
+5.27%
-0.16%
+0.16%
-0.80%
+1.46%
+3.63%Popular Instruments
51969.000
+678.400 (+1.32%)
27244.600
+280.100 (+1.04%)
7448.200
+68.200 (+0.92%)
12797.000
-1.000 (-0.01%)
59355.000
+1213.000 (+2.09%)
6271.500
+130.900 (+2.13%)
85.912
-3.945 (-4.39%)
342.370
-1.800 (-0.52%)
186.640
+5.040 (+2.78%)
4126.480
+60.810 (+1.50%)
FAQs
What is the current price of Cognition Therapeutics Inc (CGTX)?
The current price of Cognition Therapeutics Inc (CGTX) is 0.69.
What is the symbol of Cognition Therapeutics Inc?
The ticker symbol of Cognition Therapeutics Inc is CGTX.
What is the 52-week high of Cognition Therapeutics Inc?
The 52-week high of Cognition Therapeutics Inc is 1.82.
What is the 52-week low of Cognition Therapeutics Inc?
The 52-week low of Cognition Therapeutics Inc is 0.55.
What is the market capitalization of Cognition Therapeutics Inc?
The market capitalization of Cognition Therapeutics Inc is 65.33M.
Is Cognition Therapeutics Inc (CGTX) currently rated as Buy, Hold, or Sell?
According to analysts, Cognition Therapeutics Inc (CGTX) has an overall rating of Buy, with a price target of 3.33.
What is the Earnings Per Share (EPS TTM) of Cognition Therapeutics Inc (CGTX)?
The Earnings Per Share (EPS TTM) of Cognition Therapeutics Inc (CGTX) is -0.24.